Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating hypertension through renal artery denervation.
As the healthcare industry continues to embrace digital innovation, artificial intelligence continues to play an increasingly pivotal role in helping to optimize supply chain operations.
President Donald Trump confirmed that 25% tariffs on imports from Canada and Mexico, along with a 10% additional tariff on Chinese imports, will take effect March 4, according to a Feb. 27 post to Truth Social.
Since establishing its own group purchasing organization in 2018, Phoenix-based Banner Health has aimed to drive cost savings and improve supply chain efficiencies across its network.
Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas.
While President Donald Trump postponed proposed 25% tariffs against both China and Mexico, they are officially set to begin next week, according to a Feb. 25 report from CNBC.
Boston Scientific has recalled its Accolade pacemaker devices due to a manufacturing issue that could cause the devices to enter safety mode, requiring replacement.